Share

April 02, 2019; 92 (14) Editorial

Dietary patterns in early life pay dividends for midlife cognitive performance

Gene L. Bowman, Nikolaos Scarmeas
First published March 6, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007229
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
190

Share

Article Information

vol. 92 no. 14 645-646
DOI: 
https://doi.org/10.1212/WNL.0000000000007229
PubMed: 
30842297
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published March 6, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Gene L. Bowman, ND, MPH and
    2. Nikolaos Scarmeas, MD, PhD
  1. Gene L. Bowman, ND, MPH and
    2. Scientific Advisory Boards:

    1. an unpaid scientific advisor of the Horizon 2020 European Union-funded PROPAG-AGEING project, whose aim is to identify novel biomarkers for earlier diagnosis of Parkinson disease https://www.propag-ageing.eu/consortium/advisory- board/scientific-advisory-board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer's Disease, Associate Editor (2009-16)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NIA, RO1 AG043398, Grant PI, Current Co-PI, 2014-2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Nikolaos Scarmeas, MD, PhD
    3. Scientific Advisory Boards:

    1. (1)Commercial entity: Participation at a single advisory board meeting for Merck Consumer Health (2)Non-profit entity (Albert Einstein College of Medicine): Data Safety Monitoring Board chair for an NIH funded clinical trial.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Commercial entity Eisai - patient recruiting site at a phase III clinical trial of a BACE inhibitor for Alzheimer's Disease ? unrelated to the submitted work.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Marcus Institute for Aging Research (G.L.B.), Hebrew SeniorLife; Department of Medicine (G.L.B.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Department of Neurology (G.L.B.), Oregon Health & Science University, Portland; Department of Social Medicine, Psychiatry and Neurology (N.S.), National and Kapodistrian University of Athens; 1st Neurology Clinic (N.S.), Aeginition Hospital, Athens, Greece; and Taub Institute for Research in Alzheimer's Disease and the Aging Brain (N.S.), Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY.
  1. Correspondence
    Dr. Bowman genebowman{at}hsl.harvard.edu

Article usage

Article usage: March 2019 to October 2023

AbstractFullPdfSource
Mar 20191546241Highwire
Apr 20195024836Highwire
May 2019121125Highwire
Jun 201916339Highwire
Jul 20199223Highwire
Aug 201911213Highwire
Sep 20199346Highwire
Oct 201949320Highwire
Nov 201923148Highwire
Dec 20199825Highwire
Jan 20208925Highwire
Feb 202051513Highwire
Mar 20206702Highwire
Apr 20208721Highwire
May 20207512Highwire
Jun 20205011Highwire
Jul 20204113Highwire
Aug 20204937Highwire
Sep 20203901Highwire
Oct 20203901Highwire
Nov 20206726Highwire
Dec 20207004Highwire
Jan 20215701Highwire
Feb 20214501Highwire
Mar 20216712Highwire
Apr 20215402Highwire
May 20214001Highwire
Jun 20212201Highwire
Jul 20215203Highwire
Aug 20213801Highwire
Sep 20214113Highwire
Oct 20215913Highwire
Nov 20212840Highwire
Dec 20213600Highwire
Jan 20222911Highwire
Feb 20224010Highwire
Mar 20223323Highwire
Apr 20223710Highwire
May 20223024Highwire
Jun 20222502Highwire
Jul 20223503Highwire
Aug 20221300Highwire
Sep 20221310Highwire
Oct 20224411Highwire
Nov 20223711Highwire
Dec 20222700Highwire
Jan 20232600Highwire
Feb 20231301Highwire
Mar 20232330Highwire
Apr 20232300Highwire
May 20231810Highwire
Jun 20233100Highwire
Jul 20234302Highwire
Aug 20232200Highwire
Sep 20234112Highwire
Oct 20233200Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles